XBiotech Inc (NASDAQ:XBIT)
| 4.05 Delayed Data As of Sep 28 |  +0.03 / +0.75%Today’s Change | 3.00 Today|||52-Week Range 6.69 | +15.38% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $165.9M |
Company Description
XBiotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutic antibodies. Its product pipeline includes oncology, infectious diseases, dermatology and inflammatory disorders. The company was founded by John Simard on March 22, 2005 and is headquartered in Austin, TX.
Contact Information
XBiotech, Inc. 5217 Winnebago Lane Austin Texas 78744 |
Employees
Shareholders
| Other institutional | 6.92% |
| Individual stakeholders | 59.16% |
| Mutual fund holders | 4.56% |
Top Executives
| John Simard | Chairman, President & Chief Executive Officer |
| Ashley Otero | Vice President-Clinical Operations |
| Angela Hu | Chief Financial & Accounting Officer |
| Sushma Shivaswamy | Chief Scientific Officer |
| Mark Ziats | Medical Director |
